This information was published on 2026-07-14T00:11:58 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2642949 (IR 1911821) |
| (220) |
06 Mar 2026
|
| (300) |
US, 13 Feb 2026, 99652365
US, 13 Feb 2026, 99652360 |
| (511) (510) |
Class 5
Pharmaceutical and biopharmaceutical drugs and medicines for treatment of degenerative retinal diseases. Class 42 Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of degenerative retinal diseases; research and development in the pharmaceutical, life sciences and biotechnology fields. |
| (540) | YOOKANSI |
| (550) | Word |
| (730) |
Belite Bio, Inc.
|
Find out more about publications on the About page.